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Abstract
Food sources of ellagitannins (ETs) are numerous, and dietary intake of these 
compounds is estimated up to 12 mg/day in some countries, even though ETs have 
been considered in the past as not bioavailable like other tannins and were mostly 
neglected by nutritionists. Nonetheless, new insights show that ETs are bioconver-
ted by microbiota in the gut into metabolites called urolithins, which are bioavail-
able and can reach relatively high physiological concentration in the body up to 7 
days after ingestion. According to the initial structure of ETs in the food source, the 
extent of bioconversion into urolithins may differ but all urolithins are susceptible 
to exert potential health benefits. Nonetheless, due to the intervention of micro-
biota, the production and excretion of urolithins are highly variable according to 
individuals, which have led to the classification of consumers into metabotype. 
According to metabotype, the potential health benefits of ellagitannins may differ 
among consumers. In in vitro, cellular and animal studies, numerous health ben-
efits of ellagitannins and urolithins are reported mainly for the chemoprevention of 
hormone-dependent cancer and cardiovascular disease. Nonetheless, ellagitannins 
deserve closer attention from the scientific community to unravel more biological 
properties of this particular compound.
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1. Introduction
Ellagitannins are food compounds that were quite neglected by nutrionists until 
last decade. As part of tannins, they had no good reputation and they were consid-
ered as antinutritional compounds. But new scientific insights have changed these 
perspectives, and ellagitannins now attract the attention of food scientists, nutri-
tionists and consumers since the number of published papers on these compounds 
has considerably increased during the last decade. Ellagitannin is a hydrolyzable 
polymer contrary to the rest of the family of tannins and can be hydrolyzed to more 
simple monomers that can be eventually metabolized and that can become bio-
available with subsequent exposition of the body to these metabolites. For sure, if 
ellagitannins are widely present in nature, only few food sources are reported with 
relatively high content of this compound, and consequently exposition of consum-
ers to food ellagitannins is relatively low, especially in the Western diet. But given 
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the health potential of ETs, ET-rich food now belongs to the select group of func-
tional foods, and their consumption should be considerably enhanced in the future. 
Actually, given the main food source of ellagitannins such as berries and nuts, we 
can easily assume that the exposure to this compound and their metabolites was 
considerably higher in the hunter-gatherer diet than in modern time. Without 
presuming that an increase in ET intake would reduce significantly the impact of 
certain chronic diseases due to modern lifestyle, it is reasonable to argue that ETs 
have been part of our evolutionary history and they could potentially perform 
health care functions. New scientific insights presented in this chapter on the 
in vivo metabolisms of ellagitannins and the potential biological activities of gener-
ated metabolites tend to support this hypothesis. This review presents the main 
food source of ellagitannins, their general chemical structure, and how technologies 
and storage could eventually affect ellagitannin composition in processed foods. 
Then, we will review the metabolomic fate and the bioavailability of ellagitannins 
in humans, which is strongly related to the performance of intestinal microbiota, 
and finally, we will present a summary of the main biological activities, attributed 
to ETs and their derived metabolites.
2. Food occurrence of ellagitannins
Ellagitannins (ETs) are with gallotannins part of the hydrolyzable tannins and 
constitute the largest group among more than 500 hydrolyzable tannins characterized 
until now [1]. To date, more than 1000 natural ellagitannins have been identified in 
nature [2] but most of them are not preponderant in foods. The main ETs identified in 
foods (specially in fruits, nuts, and seeds) are punicalagin, sanguiin H6, lambertianin 
C, pedunculagin, vescalagin, castalagin, casuarictin and potentillin (seeds) [3].
Examples of concentration and ellagitannins identified in some foods are pre-
sented in Table 1. The occurrence of ETs in foods is restricted to a few fruits, such 
as berries of the genus Rubus (cloudberry, raspberry, blackberry, blueberry, and 
cranberry) and the genus Fragaria (strawberry), pomegranate, nuts (walnuts and 
almonds), seeds, and oak-aged wines [1, 6–8]. Recently, other ET food sources of 
Food source Ellagitannins Content equ. EA 
(mg/100 g)
Blackberries (Rubus spp..) Sanguiin H6, lambertianin D [7] 150–270 [3]
Strawberries (Fragaria ananassa) Casuarictin, pedunculagin, sanguiin H6 [7, 8] 71–83 [3]
Cloudberries (Rubus chamaemorus) Sanguiin H6, lambertianin C [7] 312 [3]
Raspberries (Rubus idaeus) Sanguiin H6, sanguiin H10, lambertianin C [7, 9] 326 [10]
Pomegranate (Punica granatum) Punicalagin [7] 58–177 [3]
Guava (Psidium friedrichsthalianum) Pedunculagin, castalin, and vescalin [5] 63 [5]
Jabuticaba (Myrciaria jaboticaba) Sanguiin H6-H10, lambertianin C [4] 900 [11]
Muscadine grapes (Vitis rotundifolia) Sanguiin H5 [7] 3–91 [7]
Purple Grumixama cherry (Eugenia 
brasiliensis)
Pedunculagin, strictinin, castalagin, vescalagin 
[12]
16 [12]
Chestnuts (Castanea sativa) Castalagin [7] 149 [13]
Pecans (Carya illinoinensis) Pedunculagin [7] 316 [13]
Walnuts (Juglans regia) Pedunculagin, casuarictin [14] 864 [13]
Table 1. 
Main food source of ellagitannins.
3Food Ellagitannins: Structure, Metabolomic Fate, and Biological Properties
DOI: http://dx.doi.org/10.5772/intechopen.86420
local importance have been identified such as jabuticaba [4], guava, [5] and gru-
mixama cherries [12]. It is interesting to note that according to a Brazilian research 
team, Jabuticaba berries from a particular variety cultivated in south Brazil have the 
highest registered ET content in fruits. Berries have almost three times more equiva-
lent EA content than walnuts and pecans and at least 15 times more than other fruits 
and nuts [6]. In the berries from the genus Rubus and genus Fragaria, total equ. EA 
content represents the most important compounds with 50–88% of total phenolic. 
Also, ET content can be considerably affected by variety, ripeness, fruit parts, 
geographic origin, climate, season, cultural practices, and mineral nutrition [6].
ET daily intake is generally low and has been estimated around 5 mg/day for 
Western diets with major contributors being the red berries mainly strawberries, 
followed by raspberries and blackberries. Given the significant seasonality of the 
production of these fruits, the exposure to ellagitannins is very uneven during the 
year. In the Scandinavian countries, where the consumption of berries increases 
considerably in summer, daily intake can reach up to 12 mg/day [6, 9] with cloud-
berry, raspberry, rose hip, strawberry, and sea buckthorn being the main contribu-
tors with content from 1 to 330 mg/100 g (fresh weight basis).
3. Chemical structure of ellagitannins
ETs are esters of hexahydroxydiphenic acid (HHDP) and a polyol, usually glu-
cose or quinic acid [3, 15, 16], that when they are hydrolyzed spontaneously suffer 
lactonization to form ellagic acid [10, 17] (Figure 1).
Chemical structure diversity among ETs is huge and is due to the possible varia-
tions in position, frequency, and stereochemistry of the HHDP units, galloylation 
extent, and/or anomeric stereochemistry of sugar moieties [17]. Thus, due to 
seemingly endless structural variations among ellagitannin, elucidating their native 
structure is often a challenge [17]. According to their chemical structure, ETs can 
readily undergo different chemical reactions such as transformation, isomerization 
and oligomerization, which finally determine overall physico-chemical properties, 
hydrolytic susceptibility, and finally biological activity in vivo [7].
The important structural diversity of ET structure is due to the different pos-
sible extent of galloylation and formation of aromatic C-glycosides, the number 
of intramolecular C-C coupling of galloyl groups and hydrolytic cleavage of 
galloyl-derived aromatic rings, the level of dehydrogenation, and oligomerization 
via oxidative C▬O [2, 17]. According to the number of HHDP groups linked to 
sugar moiety, ETs can be classified into monomeric, oligomeric, and polymeric 
ellagitannins [18].
Figure 1. 
Basic structures of ellagitannins: (A) HHDP acid (R radical); (B) galloyl unit (G radical); (C) ellagic acid.
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ETs are generally hydrolyzable in acidic or basic solutions. Even though ETs are 
quite resistant to acid hydrolysis, neutral or slightly alkaline pH (from 7.0 to 7.3) 
are the best conditions for ET hydrolysis to occur [19]. During hydrolysis, the ester 
bounds in the polymer are cleaved and HHDP is released followed by a spontane-
ous lactonization of free HHDP unit into free ellagic acid or derivatives [20]. This 
reaction is mainly used for the detection and quantification of ellagitannins, as ET 
content in food samples is often expressed as ellagic acid equivalents (Figure 2). 
Acidic and basic hydrolysis of ETs can also occur during food processing, storage, 
and passage through the stomach and duodenum [10, 16, 21]. Although most ETs 
are hydrolyzable, further C▬C coupling of polyphenolic residue with the polyol 
unit, such as in the case of vescalagin, can prevent hydrolysis [22]. In addition, ETs 
can undergo polymerization reactions during maturation of fruits or thermo-phys-
ical treatments, which can make them insoluble and eventually attached covalently 
to cell wall fragments [21]. Nonetheless, most often acidic or basic hydrolysis will 
Figure 2. 
Most common ellagitannins present in food: (D) sanguiin H5; (E) casuarictin; (F) potentillin; (G) pedunculagin; 
(H) lambertianin C; (I) punicalagin; (J) vescalagin R1: OH, R2:H o Castalagin R1:H, R2:OH.
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allow generating ellagic acid (EA) from ET even in mild conditions. As a conse-
quence, EA, the dimeric derivative of gallic acid, is often spontaneously present in 
its free form in plants, next to ET [23].
3.1 Structural changes of ETs and EA during process and storage
Different studies have pointed out that there are important changes in ETs’ 
composition during processing and storage with marked subsequent consequences 
on the bioavailability and bioactivity of these compounds [24, 25].
Mazur et al. [26] noticed a decrease of 7% of lambertianin C in red raspberry 
jam after 6 months of storage at 20°C in dark; meanwhile, ellagic acid derivatives 
and total phenolics increased by 47%. The reason was the spontaneous hydrolysis of 
ellagitannins to ellagic acid that may occur during storage. Authors showed also that 
according to the genotype of raspberry, losses of ET were more or less important. 
On the other hand, one ellagitannins, the sanguiin H6, remains remarkably stable 
during storage in this case [26]. Nonetheless, in another study, stored pasteurized 
blackberry juice showed after 6 months at 25°C a 46% loss in sanguiin H6/lamber-
tianin A, 42% loss in lambertianin C, and 72% loss in lambertianin D. Like previ-
ously, the total amount of EA measured after hydrolysis registered only minimal 
changes, which evidenced the spontaneous depolymerization of ETs into EA 
during storage. At 5°C, half-life (t1/2) of sanguiin H6 and lambertianin C was almost 
comparable (around 80 days), but when stored at 45°C, t1/2 was four times higher 
for sanguiin than for lambertianin [25]. Sanguiin H6 is a dimer and lambertianin C 
a trimer, which could explain the higher stability of this compound during stor-
age at relatively high temperature. At freezing temperature, no changes at all were 
observed over a 6-month period [24]. We can conclude that stability of ellagitannins 
during storage of processed foods depends on their chemical structure as well as the 
composition of the food matrix.
Between different processing alternatives evaluated by Hager et al. [24], can-
ning, pureeing, and freezing had little effect on blackberry (cv. Apache) ellagitan-
nins, but the removal of seeds in the press-cake generates a loss of up to 70%, 
and if juice is microfiltered, 12% more loss can be registered. In that case, some 
ellagitannins appear to be associated with cell fragments and with the mucilage that 
surrounds the seeds. In the case of Costa Rican guava, pressing appears to increase 
the content of some ETs. After pressing, an increase in pedunculagin isomer 1 
of 25% was observed, while castalagin isomers presented a significant decrease 
(40%). Authors suggest that castalagin decrease may be linked to degradation and 
not to isomerization of the compounds, since no increase in vescalagin content was 
observed [5]. Milling appeared to enhance the content of pedunculagin isomer 1 
and castalagin isomers by 34 and 31%, respectively. Actually, another study on the 
effects of mechanical and enzymatic pretreatments on the extraction of ellagitan-
nins from blackberries showed that enzymatic treatment (pectinase and cellulase) 
combined with continuous pressing enhanced significantly ET content in the juice 
(from 437 to 982 mg ellagic acid equivalents/100 g (dry basis)) [27].
Critical steps on ET content during classical industrial processing of blackberry-
based beverage in glass bottles were evaluated. Hot-filling that is characterized 
by long-term exposure of the beverage to high temperature was the operation 
that most degraded ellagitannins with losses of 80% in lambertianin C and 50% 
in sanguiin H6 in the final product. Again, sanguiin H6 showed a higher thermal 
stability than lambertianin. It was also observed that the intensity of thermal treat-
ment during process affects stability of ETs during storage [25]. But, when dealing 
with equivalent total EA content after hydrolysis, no changes were observed. On the 
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other hand, in another food source, the ripe Costa Rican guava (Psidium friedrich-
sthalianum Nied), different pasteurization treatments (71.1°C for 4 s and 60°C for 
8.2 min) were found to not affect ETs’ final content. In this case, the composition in 
geraniin, vescalagin, and pedunculagin isomers remained basically constant during 
the process [5]. The analysis of these results shows that thermal stability at high 
temperature is also affected by the chemical structure of ET.
In other processing operations such as osmotic dehydration in 50–65°Bx sucrose 
solutions (30°C), in the case of blackberry, 80% of ellagitannins were retained after 
1 h, while losses reached up to 45% after 3 h. The concentrations of the two main 
ellagitannins, lambertianin C and sanguiin H6, revealed similar patterns of varia-
tion. On the contrary, due to a much lower molecular weight, the loss of free ellagic 
acid reached up to 50% after 1 h of osmotic dehydration [23].
4. Metabolomic fate and bioavailability of ETs and EA
Many studies have proven that ETs are not bioavailable as such, and they have never 
been detected in human plasma after normal consumption of ET-rich foods [28, 29].  
Ellagitannins are probably not bioavailable because of their size (above 634 Da for one 
of the simplest ellagitannins, the sanguiin H4 (C27H22O18), up to 3740 Da for lamber-
tianin D (C164H106O104)). Their relatively high polarity and the presence of a C▬C 
linkage could also explain this situation. During ingestion, ETs can also bind some 
proteins in saliva and cause astringency, and in this case, they may not be metabolized 
further [30]. Also, some ellagitannins are resistant to acid and basic hydrolysis in 
the GI tract and they can reach almost intact the large intestine [31]. However, for 
most ETs sensitive to acidic and basic hydrolysis in the stomach and the duodenum, 
respectively, they release free ellagic acid, which is at its turn poorly bioavailable. In 
the human digestive system, the bioavailability of EA derivatives depends on the part 
of gastrointestinal tract in which these compounds are released [7]. In stomach or 
small intestine, only low level of absorption could occur, and if EA can be detected in 
plasma and urine between 1 and 5 h after ingestion of dietary ETs, generally as methyl 
and dimethyl ethers or glucuronic acid conjugates, all these EA derivatives are always 
found at very low concentrations [29, 32, 33]. Low bioavailability of EA is probably 
due to low water solubility, and to its ability to bind irreversibly to cellular DNA and 
proteins, or to form poorly soluble complexes with calcium and magnesium ions 
which affects transcellular absorption [3, 33, 34].
The extent of the degradation of ETs in the upper GI tract depends on their 
chemical structure, the food matrix, and their susceptibility to acid/base hydrolysis 
in the stomach and duodenum [29]. Therefore, some ETs can reach the intestine 
where they can exert potential biological activity and eventually some can be 
partially converted into EA by enzymes from microbiota [35].
In the lower GI tract, released EAs can be partially metabolized by gut micro-
biota into urolithins (Uro, dibenzopyran-6-one metabolites) through reduction 
of one of the two lactone groups followed by decarboxylation and sequential 
dehydroxylation involving a step-by-step reduction to tetrahydroxy (urolithin D), 
trihydroxy (urolithin C), dihydroxy (urolithin A and isourolithin A), and monohy-
droxy dibenzopyranones (urolithin B) (Figure 3) [21, 35–37].
Urolithins appear to be the main plasma and urinary biomarker after consump-
tion of ET-rich food (Table 2). Specifically, urolithin A and B and their phase II 
metabolites are the main metabolites in plasma and urine [10, 13] detected at micro-
molar concentration level. They can also be found at much higher concentration in 
some tissues or organs such as prostate gland and colon where they can accumulate 
[38, 39]. Persistence of urolithins in the body has been reported for long periods 
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after a single intake of ET-rich food. Urolithins in urine have been detected up to 
7 days [58] after dietary ET intake, and this long persistence in the body is attrib-
uted to the involvement of microbiota and enterohepatic recirculation [9, 40–42].
Therefore, urolithins have been proposed to be responsible for biological activity 
of ETs [38] as they remain in the body at relatively low concentrations but during 
a long time with potential homeopathic-like effect. However, the concentration of 
urolithins in plasma, urine, and feces varies considerably between individuals  
[38, 46, 47]. Actually, the huge inter-individual variability of microbiota composition 
affects the production of urolithins, which is mediated by microbiota. During differ-
ent studies, some individuals were labeled “low excreters” of urolithins after ingestion 
of ET-rich food, while other individuals were labeled as “high excreters of urolithins 
A or B.” Therefore, recently, a stratification of individuals according to their uro-
lithin excretion status in urine has been proposed. Three metabotypes were defined: 
metabotype A, which includes main excreters of urolithin A; metabotype B with main 
excreters of urolithin A and B; and metabotype 0 corresponding to low urolithin 
excreters [31]. This classification appeared to be consistent across multiple interven-
tion studies, independent of the ET food source, and health status of participants 
[46]. The distribution of urolithin metabotypes in adult population varies probably 
according to geography, but in a Western adult population taking into consideration 
a large cohort of individuals, UM-A is the most abundant metabotype with 55% 
followed by UM-B (34%) and UM-0 (11%) [47]. Nonetheless, a recent study reported 
by Cortés-Marín and coworkers [47] showed for the first time in a Caucasian cohort 
(5–90 years, n = 839) that age could determine the individual’s capacity to metabolize 
EA into urolithins A and B, even though the percentage of the population with low 
ability to excrete urolithins (metabotype 0) remains around 10% of the population 
whatever the age considered. The percentage of individual with metabotype A was 
higher in the case of children (80%) and decreased steadily after adolescence while 
metabotype B increased [47]. Authors also reported a significant association between 
increased physical activity and prevalence of UM-B especially between 5 and 18 years. 
On the other hand, no correlation of a specific metabotype with gender, body mass 
index, weight, health status, and diet was observed [47].
Nonetheless, most studies tend to show a strong persistence of metabotype sta-
tus for adults even though recent research showed that individuals with UM-0 sta-
tus have managed to become urolithin excreters of UM-A or UM-B after a long-term 
Figure 3. 
Metabolism of ellagitannins in the GI tract.
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exposure (up to 6 months) to a high ET source, a pomegranate-concentrated extract 
[48]. Thus, it seems that microbiota ability to catalyze the production of urolithins 
could be influenced by long-term exposure to ET-rich food by promoting growth 
of the bacteria involved in the urolithin metabolism [40]. Nonetheless, it was not 
reported if the change of metabotype remains persistent after the end of the study, 
when diet comes back to normal.
Recently, an attempt to find a correlation between urolithin metabotypes and 
enterotypes of the human gut microbiome proposed by the Human Microbiome 
Project (HMP) [39] has been made by Romo-Vaqueroa and coworkers [49] 
Source ETs Study design Metabolites Main observations
Red raspberry (300 g) 
single dose [9]
9 adults: 5 females and 
4 males (22–44 years 
old) sampling: blood 
(0, 0.5, 1, 1.5, 2, 3, 4, 
5, 6, 8, 24 h), urine (all 
until 48 h).
In urine, UA 
aglycone and phase II 
metabolites, In plasma: 
UA and UB and 
phase II derivatives 
dimethylellagic 
acid-O-gluc.
Urolithins A and B, present 
Cmax in plasma in times 
>24 h, and in urine between 
32 and 48 h after intake, 
showing high persistence in 
the body.
Pomegranate extract 
(1.8 g in 4 capsules) 
single dose [43]
10 men and 10 women 
(20–22 years old) 
sampling: blood (0, 0.5, 
1, 2, 3, 4, 5, 6 and 24 h), 
urine 0, 24, 48 and 72 h.
In urine and plasma, 
UM-0: 2 people; 
UM-A: 16 people and 
UA were quantified 
after 24, 48, and 72 h); 
UM-B: 2 people (UA 
and UB).
EA bioavailability was 
affected by the presence of 
ellagitannin, pH, and protein 
as well as low pH. A higher 
free EA intake does not 
enhance bioavailability of 
EA but promotes urolithin 
production.
Strawberry extracts 
rich in: (1) free EA; 
(2) monomeric ETs, 
and (3) dimeric ETs 
(0.1% single intake) 
[37]
30 Wistar rats (10 each 
treatment), sampling: 
feces, urine and blood, 
intestinal digesta 
(2, 4, 7 days after 
intake); samples of 
digesta, stomach, small 
intestine, cecum.
In urine, plasma, and 
intestinal digesta: UA, 
UB, UA gluc, Nasutin 
A gluc, EA dimethyl-
ether-gluc (DMEAG). 
Feces: Nasutin A and 
UA.
ETs and EA metabolites are 
found in gastrointestinal 
digesta, blood plasma, and 
urine, 2 days after intake. UA 
and DMEAG were founded 
in rats fed with free EA 
extract, Nasutin A and UA 
and Nasutin
Black raspberries 
(freeze-dried, 10% 
w/w, 6 weeks) [44]
12 male mice, sampling: 
blood and luminal, 
colon, liver, and prostate 
tissue.
Urolithin A (all mouse 
plasma, liver, prostate, 
colon, and luminal 
tissue), urolithin C 
(all tissues except 
prostate), urolithin B 
and urolithin D (only 
in luminal tissue).
Highest amount of UA was 
found in luminal tissue. UC 
was 45-fold more abundant 
in colon with respect to 
plasma. UB and UD were 
found in very low amounts 
with respect to UA. Luminal 
contents presented lower 
abundance of Clostridium 
with respect to Barnesiella in 
mice after intervention.
Pomegranate extract 
(PE) (1.8 g/day, 
3 weeks) [45]
Simulator of the 
human intestinal 
microbial ecosystem 
TWIN-SHIME®, 
coupled to human colon 
adenocarcinoma cell line 
Caco-2 cells (HTB37), 
UM-A and UM-B were 
incubated.
Large intestine: IsoUA 
and UB, detected only 
in UM-B, UA in UM-A 
and UM-B.
Production of urolithin starts 
earlier and faster in UM-B 
than in UM-A. Chronic 
PE intake improves 
UA production in both 
metabotypes, showing 
similar profiles after 18 days. 
UA production was directly 
related with Gordonibacter 
abundance.
Table 2. 
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following a cohort of 249 healthy volunteers after walnut or pomegranate extract 
ingestion for 3 days. Results showed that urolithin metabotypes and enterotypes 
(enterotype 1 (preponderance of Bacteroides), enterotype 2 (preponderance of 
Prevotella), or enterotype 3 (preponderance of Ruminococcus)) were not coinci-
dent. Only for enterotype 2, UM-A was slightly higher than UM-B. Nonetheless, 
a higher diversity of microorganisms in UM-B individual with respect to UM-A, 
and even more with respect to UM-0, was found. Actually, urolithin B produc-
tion requires a more complex enzymatic arsenal than urolithin A. It was observed 
that a higher relative importance of microorganisms from the Coriobacteriaceae 
family tends to be correlated with a higher preponderance of UM-B with respect 
to UM-A and even more with respect to UM-0. Two bacterial strains isolated 
from human microbiota, Gordonibacter urolithinfaciens and Gordonibacter pame-
laeae from Eggerthellaceae family, which was previously considered as part of 
Coriobacteriaceae family, showed ability in vitro to transform EA into urolithin 
C [50]. Recently, a specific strain also isolated from human microbiota was able 
to further metabolize EA up to isourolithin-A and was named as a consequence 
Ellagibacter isourolithinifaciens [50, 51]. Nonetheless, until now, no other bacterial 
strains that could metabolize EA to urolithins B have been reported.
Another factor that can impact the rate of urolithin production in vivo is the 
food source and the chemical structure of ingested ETs. For example, more uro-
lithins in prostate from patients who consumed walnuts rather than in patients 
who consumed pomegranate juice, even when the latter had a higher ET content, 
were found. [14]. Also, it appears that there is a kind of saturation of the metabolic 
pathways as the amount of urolithins excreted in vivo remains apparently indepen-
dent of the quantity of ETs ingested. This was observed for different food sources 
of ETs consumed in normal quantities such as strawberries, raspberries, walnuts, 
and oak-aged red wine [52]. Probably, there exists a consumption threshold below 
which urolithin excretion cannot be detected.
At last, the bioavailability of ETs and EA could be affected by food processing. In 
a clinical study, 16 healthy volunteers consumed approximately the same quantity of 
ET but in different presentation: pomegranate juice (PJ), pomegranate polyphenol 
liquid extract (POMxl), and pomegranate polyphenol powder extract (POMxp). As 
a result, there were no statistical differences in the level of EA in plasma between the 
three interventions over a 6-h period. Only, POMxp presented a longer lag-time to 
reach the peak of maximum concentration compared to PJ and POMxl [53]. A similar 
study was performed with 20 healthy volunteers comparing pasteurized strawberry 
juice (80°C for 5 min) and the equivalent fresh fruits. In this case, processing did 
not affect the urinary excretion of urolithins. Although the amount of free EA was 
increased 2.5-fold during processing, no effect on the urinary excretion of urolithins 
was observed [40]. Actually, further researches are required for a more definitive 
assessment on the effect of processing on the production and excretion of urolithins.
5. Main biological activities of ETs and their metabolites
Ellagitannins, ellagic acid, and their metabolites have been reported to exhibit 
numerous beneficial effects on human health including anti-inflammatory, anticancer, 
antioxidant, prebiotic, and cardioprotective properties [21, 54]. However, in vitro 
studies with cells or in vivo studies with animals could give inconsistent or untranslat-
able information about bioactivity of these metabolites in humans. Abundant litera-
ture shows for example the impact of ETs and EA on cells from organs that are not part 
of the GI tract and the results are absolutely controversial and inconsistent with actual 
knowledge. The potential health effect of ETs and possibly EA can only be exerted 
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within the GI tract, as these compounds are poorly bioavailable. On the other hand, 
urolithin production is mediated by microbiota and studies on animals can hardly 
be extrapolated to humans, except in the case of germ-free animals used in human 
microbiota-related researches. Therefore, in this review, even though research studies 
are much more scarce, we will report results of biological activities of ETs and EA only 
related with the GI tract, and for urolithins, given the importance of microbiota in 
their metabolism, we will focus only on the results of clinical trials with humans.
5.1 Effect of ETs and EA in GI tract
In in vitro model of colon cancer, ellagic acid was found to have a significant 
antiproliferative effect inducing apoptosis of cancer Caco-2 cells via a mitochon-
drial pathway and without side effects on normal colon cells [55]. In another study 
in rats, EA showed anti-inflammatory properties by iNOS, COX-2, TNF-α, and 
IL-6 downregulation due to NF-κB repression. Authors conclude that EA may exert 
a chemopreventive effect on colon carcinogenesis [56]. Furthermore, ETs and EA 
have a high antioxidant activity (even higher than urolithins) and could be highly 
efficient to scavenge oxygen free radicals and eventually prevent inflammation and 
colon cancer [21]. At last, in nasopharyngeal carcinoma cell lines (NPC-BM1), EA 
has showed ability to downregulate Bcl-2 and DNA fragmentation, by increasing 
caspase-3 enzymatic activity, which reduces telomerase activity [57].
5.2 Effect of urolithins
Numerous studies have demonstrated the metabolism of EA into urolithins, in 
approximately 12–24 h, with persistence of urolithins up to 4–7 days in urine after 
dietary intervention [9, 41, 42, 58], and research interest has shifted to the potential 
effect of urolithins on health. Actually, urolithins may exert a much more consistent 
effect at the systemic level than EA with concentration in body fluids at least one 
order of magnitude higher in body fluids. Actually, EA has been reported in plasma 
at concentration around some nanomoles per liter, while urolithins have been 
reported at concentration level up to 80 μmol/l [58].
5.2.1 Anti-inflammatory effect
Inflammation is a primary defensive response against harmful factors that 
involved different mechanisms including the immune system cells [8]. The impact 
of urolithins on inflammatory processes has been well established on various 
in vivo and in vitro models [59–61]. In in vitro models, urolithin aglycones have 
been tested, while in vivo glucuronide conjugates of urolithins are the predominant 
metabolites present in plasma, tissues, and urine [62]. Urolithin aglycone is highly 
bioactive against inflammation, but some authors suggest that urolithin conjugate 
may be even more active. In a study, in which urolithin conjugates (iso-Uro-A-gluc, 
Uro-A-gluc, and Uro-B-gluc) were isolated from urine of a volunteer after ingestion 
of pomegranate juice (0.5 L/day), walnuts (30 g/day), hazelnuts (30 g/day), and 
fresh raspberries (200 g/day) for 5 days, the cleavage of glucuronides by endogenous 
β-glucuronidases released by human neutrophils was observed . β-Glucuronidase is 
an enzyme that is released from inflammatory cells and the lysosomes of necrotic 
cells, and high levels can be found in most solid tumors. Therefore, a wide number 
of structurally diverse glucuronide prodrugs have been designed with the aim of 
enhancing the selectivity of cancer chemotherapy. The results suggest that the selec-
tive activation of urolithin glucuronides by β-glucuronidase could locally increase 
the concentration of bioactive urolithin aglycones. More clinical trials are needed to 
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better understand the anti-inflammatory response attributed to urolithin [62] and 
the impact on the suppression of the immune responses, especially on inflammation-
associated diseases, like cardiovascular diseases and cancer [63].
5.2.2 Chemoprevention of cancers
Several in vitro and in vivo (animal or human) studies have reported a protective 
effect of urolithins on prostate cancer [64–66]. However, recent clinical interventions 
have pointed out inconsistent results. A recent review compiles the data of clini-
cal trial studies after consumption of pomegranate juice or extracts and discusses 
whether urolithin could inhibit or slow the growth of prostate cancer in patients. The 
authors reported a significant increase in urolithin A in prostate but a nonsignificant 
reduction in 8-hydroxy-2-deoxyguanosine, a marker of oxidation in cancer tissue, 
for neoadjuvant patients subjected to radical prostatectomy after pomegranate intake 
(1200 mg polyphenols/day) compared with placebo in a large trial (4 weeks, n = 33) 
[67]. Similar results with muscadine grape skin extract have evidenced no benefit on 
recurrent prostate cancer patients in spite of urolithin A increase [68]. Nonetheless, 
authors [67] have noted in a specific group of patients (named AA genotype), which 
has been previously associated with more hostile prostate cancer and more sensitivity 
to antioxidants, a significant increase in a prostate-specific antigen doubling times 
(PSADT), an antigen that is claimed to slow tumor growth.
After an acute intake of grumixama cherry juice (Brazilian) by healthy women 
(n = 10), the antiproliferative activity of urolithins against breast cancer cells 
(MDA-MB-231) was evaluated. The extracts of urine exhibited seven urolithins, 
mainly urolithin C and urolithin A. Those extracts obtained during 2–4 h after juice 
intake presented the highest inhibition of proliferation of MDA-MB 231 breast cancer 
cells. This inhibition was attributed to a significant G2/M cell cycle arrest (apoptosis) 
occurred in MDA-MB-231 cells, and was demonstrated by the increase in sub-G0/
G1 populations. Additionally, the authors linked this inhibition to a possible synergy 
among anthocyanins and urolithins [12]. Then, the modulation of the positive- 
estrogen receptor in breast cancer cells (MCF7) is probably one of the potential 
actions of urolithin conjugates. On the other hand, in a study realized with breast 
cancer patients (n = 19) who consumed a mixed extract (493.4 mg phenolics/day) 
containing pomegranate, orange, lemon, olive, cocoa, grape seed extracts plus resve-
ratrol, theobromine, and caffeine, it was shown that the main metabolites detected in 
breast tissues were urolithin-A-3-O-glucuronide. Nonetheless, no antiproliferative or 
estrogenic/antiestrogenic activities in MCF-7 breast cancer cells were reported [69].
Ellagitannin gut microbiota-derived metabolites have shown a wide range of 
colon anticancer effects both in cellular and animal studies [70–72]. However, the 
current clinical evidence that confirms their colorectal cancer (CRC) chemopre-
ventive effect in humans is still very weak. A study evaluated the modification 
of microRNAs (miRs) expression, one CRC biomarker, in normal and malignant 
colonic tissues from CRC patients after pomegranate extract intake (900 mg/day 
before surgery). As a result, pomegranate consumption seems to moderate the 
modulation of various specific miRs in colon tissue, but there was no association 
between tissue urolithins and the detected miRs changes, which were attributed to 
a possibly critical surgery alteration in miRs levels that did not allow to discrimi-
nate between malignant and normal tissues [73]. Another more recent study in 
35 patients with colorectal cancer (CRC), daily supplemented with pomegranate 
extracts, was conducted to evaluate the expression of various CRC-related genes 
in normal and cancerous colon tissues. Before (biopsies) and posterior (surgical 
samples) to pomegranate intake (5-35 days). Despite the consumption of pome-
granate extract was significantly associated with a balancing effect in the expression 
Tannins - Structural Properties, Biological Properties and Current Knowledge
12
of genes regulated by the experimental protocol, these results were not associated 
with the individual metabotypes or the levels of urolithins and EA in the colon 
tissues. Consequently, the in vitro effects were not reproduced in vivo evidencing 
discrepancy between results [70]. In general, we can conclude that there is a lack of 
clinical interventions with ET-rich food in humans; besides, these kinds of studies 
are essential to corroborate the real effect of urolithins on cancer.
5.2.3 Reducing risks of cardiovascular disease (CVD)
The gut microbiota is frequently presented as a key factor in the evolution of 
obesity and cardiovascular disorders (CVD) [74]. One clinical study clustered 
urolithin metabotypes (UMs) of 18 healthy overweight/obese subjects with the aim 
of correlating metabotype status with CVD biomarkers after pomegranate extract 
consumption. In baseline and before UM clustering, the whole group exhibited mild 
dyslipidemia, and after clustering, only the serum lipid profile of UM-B individu-
als (n = 15) showed moderate risk values in total cholesterol, intermediate-LDL-
cholesterol, as well as other serum lipids related to CVD risk. After ET intervention, 
only blood biomarkers of UM-B subjects were improved after pomegranate extract 
intake, reducing their CVD risk. Interestingly, a dose-dependent behavior was 
notable only in UM-B patients [48].
Another experiment comparing healthy patients with patients with metabolic 
syndrome (MetS), both consuming walnuts, showed that urolithin A only was 
inversely correlated with glycaemia in MetS individuals. Additionally, when MetS 
patients with UM-A were treated with statin, their lipid profile became similar to 
healthy individuals. This was not the case for individuals with UM-B [74].
Another study showed that the increasing relative importance within the 
microbiota of bacteria from the Coriobacteriaceae family such as Olsenella, 
Senegalimassilia, and Slackia, which characterized UM-B status, was positively cor-
related with blood cholesterol levels and normal BMI [49].
Endothelial dysfunction and inflammation are both usual events that occur in the 
development of atherosclerosis. The correlation between the plasma urolithin metabo-
lites and improvement in endothelial function after red raspberry intake was reported. 
Endothelial function measured as flow media vasodilation (FMD) presented two peaks, 
first at 1–2 h after intake, linked with EA plasma peak concentration, and second peak at 
24 h, associated with urolithin-3-glucuronide and urolithin-A-sulfate absorption peaks. 
Similar results were reported by other authors in cranberry and blueberry juice interven-
tions [75], but it was shown that effect was the same when consuming 200 or 400 g of 
raspberries. Additional distinctive key factors in atherosclerosis development have been 
reported, as the capacity of monocytes to adhere to endothelial cells and the uptake and 
efflux of cholesterol by macrophages. In vitro, urolithins and EA were able to reduce 
adhesion of THP-1 monocytes to human umbilical vein endothelial cells and reduce 
secretion of sVCAM-1 and IL-6, a cellular adhesion molecule and a pro-inflammation 
cytokine, respectively. Also, urolithin C and EA were associated with decreased accumu-
lation of cholesterol in THP-1–derived macrophages [76]. Attenuation of THP-1 also was 
reported in the presence of urolithin A in endothelial cells and also reduced considerably 
the expressions of ICAM-1 and MCP-1, an intercellular adhesion molecule and a mono-
cyte chemotactic protein, respectively [77].
6. Concluding remarks
Ellagitannins are present in considerable amounts only in some specific food 
sources such as berries and nuts, but some tropical fruits deserve attention. Their 
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diverse structure can be modified during food processing resulting in free ET 
and EA derivatives, which are poorly bioavailable. After ingestion, most ETs are 
spontaneously converted into EA, which is poorly bioavailable and can be used as 
substrate by gut microbiota. The main products resulting from the action of gut 
microbiota on EA are urolithins. The main biomarkers in blood and urine of ET-rich 
food exposure are urolithins A and B. Nonetheless, there is an important interindi-
vidual variability in the excretion of urolithins, and this observation has led to the 
classification of the population in three metabotypes: the “low urolithin” excreters 
that represent approximately 10% of the population; the “urolithin A” excreters, 
the most important group with approximately 55% of individuals; and finally, the 
“urolithin A and B excreters” that represent around 35% of the population. The 
metabotype status appears to be quite persistent although it can change during 
life span and the constant exposure to ET-rich food appears to increase urolithin 
production. Microorganisms from the Coriobacteriaceae family were identified as 
urolithin producers and the relative importance of this family within the microbiota 
was apparently correlated with the metabotype. The stratification of individuals 
by their metabotype was essential to overcome inconsistencies during clinical trial, 
and it must be taken into account in all future intervention studies. The positive 
biological effects of ETs and EA at the level of the GI tract are consistent and 
reported by various authors. For urolithins, the panorama is more confused, and 
more long-term clinical intervention studies with human are required. Nonetheless, 
at the end of this review, the potential health effect of ET-rich foods is definitely 
promising and they deserve to be part of a healthy diet as functional foods.
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